These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 135384)

  • 1. Antibody-dependent cellular cytotoxicity and chronic renal allograft rejection.
    Thomas JM; Thomas FT; Kaplan AM; Lee HM
    Transplantation; 1976 Aug; 22(2):94-100. PubMed ID: 135384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant monitoring of donor-recipient compatibility.
    Thomas F; Thomas J; Mendez G; Kirchoff C; Lee HM
    Transplantation; 1977 Dec; 24(6):442-8. PubMed ID: 145674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct cell mediated lympholysis by peripheral blood lymphocytes from renal allograft recipients.
    Grunnet N; Kristensen T
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):41-4. PubMed ID: 133456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract]   [Full Text] [Related]  

  • 5. An immunological study of renal allograft rejection using the direct macrophage inhibition test.
    Turnipseed WD; Cerilli J
    Transplantation; 1975 Nov; 20(5):414-9. PubMed ID: 1108315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of in vitro donor-specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLR.
    Ghobrial II; Morris AG; Booth LJ
    Transpl Int; 1994; 7(6):420-7. PubMed ID: 7865106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological monitoring of long-surviving renal transplant recipients.
    Thomas J; Thomas F; Mendez-Picon G; Lee H
    Surgery; 1977 Feb; 81(2):125-31. PubMed ID: 138208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated cytotoxicity: a predictor of chronic rejection in pediatric HLA haploidentical renal transplants.
    Alexander SI; Younes SB; Yunis JJ; Zurakowski D; Mirza N; Dubey D; Drew MP; Harmon WE; Yunis EJ
    Transplantation; 1997 Jun; 63(12):1756-61. PubMed ID: 9210500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct cell mediated lympholysis. A test of allograft-rejection in human kidney recipients.
    Grunnet N; Kristensen T; Kornerup HJ; Kissmeyer-Nielsen F
    Tissue Antigens; 1975 May; 5(4):280-5. PubMed ID: 50635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of blocking antibody after human renal transplantation.
    Miller J; Lifton J; Rood F; Kyriakides G; Gajl-Peczalska KY; Yunis EJ; Hattler BG
    Surgery; 1974 Jul; 76(1):129-41. PubMed ID: 4135311
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating antibodies in allograft recipients.
    Revillard JP; Betuel H
    Adv Nephrol Necker Hosp; 1975; 5():257-81. PubMed ID: 127522
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and nonspecific cytotoxicity of leukocytes from human renal allograft recipients against donor fibroblasts.
    Pierce GE; Barth RF; Vessella RL; Cross DE; Stewart CS
    Transplantation; 1979 Mar; 27(3):156-62. PubMed ID: 373179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cellular immune response in HL-A-identical renal transplant recipients.
    Turnipseed WD; Folger MR; Cerilli J
    Transplantation; 1974 Apr; 17(4):341-5. PubMed ID: 4274662
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.
    Shons AR; Etheredge EE; Callender CO; Schmidtke JR; Simmons RL; Najarian JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):464-70. PubMed ID: 4278196
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.